Related references
Note: Only part of the references are listed.Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
Nan Wang et al.
NATURE MEDICINE (2014)
Huntington disease: natural history, biomarkers and prospects for therapeutics
Christopher A. Ross et al.
NATURE REVIEWS NEUROLOGY (2014)
Motor, emotional and cognitive deficits in adult BACHD mice: A model for Huntington's disease
Yah-se K. Abada et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
A report of two novel NR5A1 mutation families: possible clinical phenotype of psychiatric symptoms of anxiety and/or depression
Ayuko S. Suwanai et al.
CLINICAL ENDOCRINOLOGY (2013)
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
Sofia Hult Lundh et al.
HUMAN MOLECULAR GENETICS (2013)
Genetic labeling of steroidogenic factor-1 (SF-1) neurons in mice reveals ventromedial nucleus of the hypothalamus (VMH) circuitry beginning at neurogenesis and development of a separate non-SF-1 neuronal cluster in the ventrolateral VMH
Clement C. Cheung et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice
Thibault Renoir et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Choosing an animal model for the study of Huntington's disease
Mahmoud A. Pouladi et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice
Mahmoud A. Pouladi et al.
HUMAN MOLECULAR GENETICS (2012)
Steroidogenic Factor 1 and the Central Nervous System
T. Buedefeld et al.
JOURNAL OF NEUROENDOCRINOLOGY (2012)
Central nervous system control of metabolism
Martin G. Myers et al.
NATURE (2012)
Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse
Sofia Hult Lundh et al.
PLOS ONE (2012)
Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits
Sofia Hult et al.
CELL METABOLISM (2011)
SF-1 in the ventral medial hypothalamic nucleus: A key regulator of homeostasis
Ki Woo Kim et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus
Ki Woo Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses
Sanaz Gabery et al.
ACTA NEUROPATHOLOGICA (2010)
Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression
Mahmoud A. Pouladi et al.
HUMAN MOLECULAR GENETICS (2010)
The Clinical and Genetic Features of Huntington Disease
Aaron Sturrock et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis
Charlotte Soneson et al.
NEUROBIOLOGY OF DISEASE (2010)
Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease
Terence Y. C. Pang et al.
HUMAN MOLECULAR GENETICS (2009)
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled et al.
NEUROBIOLOGY OF DISEASE (2009)
Hypothalamic involvement in Huntingtons disease: an in vivo PET study
Marios Politis et al.
BRAIN (2008)
Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome
Nathan C. Bingham et al.
ENDOCRINOLOGY (2008)
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice
Michelle Gray et al.
JOURNAL OF NEUROSCIENCE (2008)
Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus
Ki Woo Kim et al.
MOLECULAR ENDOCRINOLOGY (2008)
Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior
Liping Zhao et al.
MOLECULAR ENDOCRINOLOGY (2008)
GABA/benzodiazepine receptors in the ventromedial hypothalamic nucleus regulate both anxiety and panic-related defensive responses in the elevated T-maze
Cintia Heloina Bueno et al.
BRAIN RESEARCH BULLETIN (2007)
Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain
Jeremy M. Van Raamsdonk et al.
NEUROBIOLOGY OF DISEASE (2007)
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Alicia A. Walf et al.
NATURE PROTOCOLS (2007)
Development of the ventromedial nucleus of the hypothalamus
Kristy M. McClellan et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2006)
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice
Alejandro Lloret et al.
HUMAN MOLECULAR GENETICS (2006)
Body weight is modulated by levels of full-length Huntingtin
JM Van Raamsdonk et al.
HUMAN MOLECULAR GENETICS (2006)
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis
H Dhillon et al.
NEURON (2006)
Orexin loss in Huntington's disease
A Petersen et al.
HUMAN MOLECULAR GENETICS (2005)
Comparative localization of Dax-1 and Ad4BP/SF-1 during development of the hypothalamic-pituitary-gonadal axis suggests their closely related and distinct functions
Y Ikeda et al.
DEVELOPMENTAL DYNAMICS (2001)
Share Paper
